一種生物兼容聚丙烯的無壓力中尿道懸帶，被設計用于治療女性小便失禁。該懸帶已經獲得了美國食品藥品管理局的許可。

這種尿道懸帶是CL醫療器械公司(Lyon, France)的產品，已經成功投放歐洲市場。根據CL公司的一項排他性協議，Uroplasty公司(Minneapolis, MN, USA)正在美國和英國市場制造這種懸帶，并將一種叫做I-STOP的設備推向市場。

Uroplasty已經研發或者正在研發幾種用于治療排泄功能障礙的其他產品。這包括急癥PC神經調制系統，一種創傷性很小的神經刺激設備，用于在辦公室治療急癥小便失禁的膀胱過度活躍癥狀以及尿頻尿急。Macroplastique是另外一種泌尿科產品，為男性和女性小便失禁患者提供可移植的軟組織罐裝產品。當把Macroplastique注射入尿道周圍組織，就能夠穩定和“罐裝”尿道周圍的組織，提高周圍肌肉的功能控制尿液的排泄。

Sling to Treat Female Incontinence
 
A biocompatible polypropylene, tension-free, mid-urethral sling is designed for the treatment of incontinence in women. The sling has been cleared by the U.S. Food and Drug Administration (FDA).

The product of CL Medical (Lyon, France), the sling has been successfully launched in European markets. Under an exclusive agreement with CL Medical, Uroplasty, Inc. (Minneapolis, MN, USA) is manufacturing the sling and marketing the device, called I-STOP, in the United States and the United Kingdom.

Uroplasty has developed or is developing several other products for voiding dysfunction. These include the Urgent PC neuromodulation system that is a minimally invasive nerve stimulation device for office-based treatment of overactive bladder symptoms of urge incontinence and urinary urgency and frequency. Macroplastique implants, another Uroplasty product, offer an implantable soft tissue bulking product for both male and female incontinence. When Macroplastique is injected into tissue around the urethra, it stabilizes and “bulks” tissues close to the urethra, providing the surrounding muscles with increased capability to control the release of urine.